{"schema_version":"secwatch.filing_event.v1","accession":"0001387131-23-009113","form_type":"8-K","ticker":null,"cik":"0000887247","company_name":"DMK PHARMACEUTICALS Corp","filed_at":"2023-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.888731+00:00","generated_at":"2026-06-12T22:40:04.691229+00:00","sec_items":["2.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Adamis Pharmaceuticals closes sale of Conway, AR property for $2M to FarmaKeio Pharmacy Network","bullets":["Sold building, real property, equipment, and IP for $2M cash before estimated fees of ~$232,700.","Buyer is unaffiliated third party FarmaKeio Pharmacy Network, LLC.","Property formerly used by discontinued compounding pharmacy business."],"urls":{"canonical":"https://secwatch.observer/filing/0001387131-23-009113","json":"https://secwatch.observer/filing/0001387131-23-009113.json","markdown":"https://secwatch.observer/filing/0001387131-23-009113.md","text":"https://secwatch.observer/filing/0001387131-23-009113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/887247/000138713123009113/0001387131-23-009113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/887247/000138713123009113/admp-8k_072523.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T22:40:04.691229+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0715cea58681422ce3e436882dd73408e1fc9744","claim":"DMK PHARMACEUTICALS Corp completed a disposition involving FarmaKeio Pharmacy Network, LLC for $2,000,000, before commissions, fees and closing costs estimated at approximately $232,700 (closed 2023-07-25).","evidence_excerpt":"we sold the building, real property, personal property, equipment and related assets. The total aggregate consideration for the sale of the real property and other assets was $2,000,000, before commissions, fees and closing costs estimated at approximately $232,700. The Agreement includes a number customary provisions addressing matters such as title and title","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/887247/000138713123009113/0001387131-23-009113-index.htm","confidence":0.95,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"FarmaKeio Pharmacy Network, LLC"},{"label":"Consideration","value":"$2,000,000, before commissions, fees and closing costs estimated at approximately $232,700"},{"label":"Closing","value":"2023-07-25"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}